# Molecular Mind's MMDesign hits 18 of 19 antibody design projects in lab tests

> Original title: 19个项目18个成功，6个GPCR靶点全获命中！国产AI制药再破技术天花板

- Source: QbitAI
- Published: 2026-10-28T08:59:00.000Z
- Bad Influence: https://badinfluence.news/items/k2da382jayiuo0mzzkxeus4iq
- Original: https://www.qbitai.com/2026/10/506055.html

## Summary

Molecular Mind says its MMDesign platform produced experimentally confirmed binders in 18 of 19 de novo design projects, a 94.7% project success rate. The company reports 139 of 453 tested candidates bound, a 30.7% candidate hit rate, including all six GPCR targets tested, with best affinities in the nanomolar range.
